David Cohen
Dermatology · New York, NYNPI 1730179680
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $2,194,844 of the $2,961,968 with a category attached, or 74.1%. Kadmon Corporation LLC accounts for 82.4% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $2,360,550 and has fallen 97.6% since, to $55,557 in 2025. Among dermatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 606 payments — averaging $4887.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kadmon Corporation LLC$2.4M
- LEO Pharma Inc.$120K
- Dermira, Inc.$119K
- LEO Pharma AS$60K
- UCB SA$50K
- AbbVie$45K
- plus $129K from 19 others
What the payments were for
- Consulting fees$464,18116%
- Speaking & faculty fees$267,4739%
- Travel & lodging$23,4691%
- Food & beverage$12,0010%
- Ownership interest$2,194,84474%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kadmon Corporation LLC | 28 | $2,439,210 |
| LEO Pharma Inc. | 27 | $120,346 |
| Dermira, Inc. | 41 | $118,602 |
| LEO Pharma AS | 119 | $59,822 |
| UCB SA | 32 | $49,952 |
| AbbVie | 89 | $45,495 |
| Incyte Corporation | 73 | $22,921 |
| Amgen | 68 | $22,824 |
| Pfizer | 21 | $20,854 |
| Janssen Global Services, LLC | 23 | $14,956 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $10,800 |
| Sanofi | 13 | $9,582 |
| UCB, Inc. | 11 | $8,311 |
| Lilly USA, LLC | 16 | $7,096 |
| Novartis | 2 | $4,445 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $2,900 |
| Johnson & Johnson | 18 | $2,656 |
| Dermavant Sciences, Inc. | 4 | $423 |
| Arcutis Biotherapeutics, Inc. | 11 | $419 |
| Sun Pharmaceutical Industries Inc. | 1 | $110 |
| AstraZeneca | 1 | $108 |
| Regeneron Healthcare Solutions, Inc. | 1 | $62 |
| Regeneron | 1 | $38 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,961,968 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 56 | $205,975 |
| Dupixent SyringeDupilumab | 23 | $106,797 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 11 | $12,820 |
| Tacrolimus | 35 | $3,029 |
| Ciclopirox | 18 | $1,121 |
| Doxycycline Hyclate | 22 | $760 |
| Fluorouracil | 13 | $733 |
| Desonide | 25 | $424 |
| Mupirocin | 24 | $224 |
| Econazole Nitrate | 11 | $151 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
- Mark LebwohlNew York$733K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.